Seres Therapeutics

Seres Therapeutics is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Founded by Flagship VentureLabs, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. Current candidates span infectious, metabolic, and inflammatory diseases.
Cambridge, US
86 (est)
Seres Therapeutics was founded in 2010 and is headquartered in Cambridge, US

Seres Therapeutics Locations

Cambridge, US

Seres Therapeutics Metrics

Seres Therapeutics Summary

Market capitalization

$406 M

Closing share price

Seres Therapeutics's latest market capitalization is $406 M.

Seres Therapeutics Market Value History

Seres Therapeutics News

Seres Therapeutics Company Life